Macquarie Asset Management, an investment management company, released its “Macquarie Large Cap Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the Catalyst® Cortisol Test, which measures real-time quantitative cortisol ...

Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders Provided by PR Newswire Jun 5, 2025, 4: ...

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. “IDEXX drove solid execution in ...

May 1 (Reuters) - Animal diagnostics maker IDEXX Laboratories (IDXX.O), opens new tab on Thursday raised its annual profit forecast after it beat Wall Street estimates for quarterly profit, as it ...

And IDXX sells other analyzers, not just Catalyst One, each with its set of proprietary consumables, so once a consumer buys an analyzer, the company benefits from recurring revenues from consumables.

Shares of IDEXX Laboratories (IDXX) surged 10% to lead S&P 500 gainers Monday after the provider of veterinary healthcare products and services reported better-than-anticipated results on demand ...

IDEXX Laboratories, Inc. has a 12 month low of $372.50 and a 12 month high of $583.39. The firm has a 50-day simple moving average of $487.95 and a 200 day simple moving average of $495.89.

I think the menu expansion is quite important for IDEXX’s catalyst platform, as the new menu will provide veterinarians with quantitative results at the point-of-care in under 10 minutes.

Red Arrow Studios International has rebranded as Seven.One Studios International. The change will come into effect immediately, and eliminates the brand disparity between Seven.One and Red Arrow ...